Vipresso sustained release tablets 150mg, manufactured by Kyowa Pharmaceutical Industry, contain Quetiapine fumarate. This atypical antipsychotic medication is used to treat schizophrenia and bipolar disorder. The product has a YJ code of 1179042G2021 and is standardized as 150mg 1 tablet.
Vipresso sustained release tablets 150mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
